A center for testing genome editing in rodents
Official title: MU Rodent Testing Center for Somatic Cell Genome Editing
Funded at University of Missouri-Columbia · NIH-10773783 · Data updated 2026-11-12
This study is creating a special center to help scientists test new gene-editing treatments using rats and mice, making it easier to turn these discoveries into real help for people with diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $423,027 |
| NIH project number | 1U42OD035739-01 |
| Project ID | NIH-10773783 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with genetic disorders that may be targeted by genome editing therapies.
✕Less likely to help
Patients with conditions that are not amenable to genetic interventions or those who do not have access to clinical trials may not benefit from this research.
What this research studies
This research focuses on developing a specialized center that provides testing services for genome editing technologies using rodent models, particularly rats and mice. The center aims to accelerate the translation of these technologies into clinical applications by offering access to a variety of rodent disease models and ensuring high-quality standards in animal care. The team involved has extensive expertise in animal modeling and comparative medicine, which will enhance the rigor and reproducibility of research outcomes. By facilitating the testing of genetic interventions, this center aims to support advancements in therapeutic strategies for human diseases.
Why it matters
Potential benefit: If successful, this research could lead to more effective gene therapies for various human diseases.
How similar studies have gone: Other research has shown success in using rodent models for testing genome editing technologies, indicating that this approach is promising and not entirely novel.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Bryda, Elizabeth C — University of Missouri-Columbia
- Study coordinator: Bryda, Elizabeth C
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.